IBERE PHARMACEUTICALS

Ibere Pharmaceuticals (Nasdaq: IBER) is a blank check company that completed its initial public offering in 2021, targeting acquisition opportunities in the pharmaceutical and life sciences sector. The company filed a Form 10-Q with the Securities and Exchange Commission on November 12, 2021, reflecting its status as an active SPAC in the search phase for a qualifying business combination. Focused on healthcare and biopharma deal flow, IBER was part of a wave of sector-specific SPACs that emerged during the 2021 surge in blank check activity. Visit SpacDesk and sign up for full data, filings history, and deal-tracking on IBER and hundreds of other active and completed SPACs.